1,199
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Delivery of radix ophiopogonis polysaccharide via sucrose acetate isobutyrate-based in situ forming systems alone or combined with its mono-PEGylation

, , , , &
Pages 267-277 | Received 07 Nov 2017, Accepted 05 Jan 2018, Published online: 15 Jan 2018

References

  • Auyeung KK, Han QB, Ko JK. (2016). Astragalus membranaceus: a review of its protection against inflammation and gastrointestinal cancers. Am J Chin Med 44:1–22.
  • Bao L, Cai X, Wang J, et al. (2016). Anti-fatigue effects of small molecule oligopeptides isolated from Panax ginseng C. A. Meyer in mice. Nutrients 8:807–17.
  • Brodbeck KJ, DesNoyer JR, McHugh AJ. (1999). Phase inversion dynamics of PLGA solutions related to drug delivery. Part II. The role of solution thermodynamics and bath-side mass transfer. J Control Release 62:333–44.
  • Chen S, Singh J. (2005). Controlled delivery of testosterone from smart polymer solution based systems: in vitro evaluation. Int J Pharm 295:183–90.
  • Chu X, Liu XJ, Qiu JM, et al. (2016). Effects of Astragalus and Codonopsis pilosula polysaccharides on alveolar macrophage phagocytosis and inflammation in chronic obstructive pulmonary disease mice exposed to PM2.5. Environ Toxicol Pharmacol 48:76–84.
  • Dong S, Wang S, Zheng C, et al. (2011). An in situ-forming, solid lipid/PLGA hybrid implant for long-acting antipsychotics. Soft Matter 7:5873–8.
  • Fan S, Zhang J, Nie W, et al. (2017). Antitumor effects of polysaccharide from Sargassum fusiforme against human hepatocellular carcinoma HepG2 cells. Food Chem Toxicol 102:53–62.
  • Fernando IP, Nah JW, Jeon YJ. (2016). Potential anti-inflammatory natural products from marine algae. Environ Toxicol Pharmacol 48:22–30.
  • Geng Z, Luo X, Zhang Z, et al. (2016). Study of an injectable in situ forming gel for sustained-release of Ivermectin in vitro and in vivo. Int J Biol Macromol 85:271–6.
  • Greenwald RB, Gilbert CW, Pendri A, et al. (1996). Drug delivery systems: water soluble taxol 2’-poly(ethylene glycol) ester prodrugs-design and in vivo effectiveness. J Med Chem 39:424–31.
  • Han SY, Hu MH, Qi GY, et al. (2016). Polysaccharides from polygonatum inhibit the proliferation of prostate cancer-associated fibroblasts. Asian Pac J Cancer Prev 17:3829–33.
  • Haruta K, Otaki N, Nagamine M, et al. (2017). A novel PEGylation method for improving the pharmacokinetic properties of anti-interleukin-17A RNA aptamers. Nucleic Acid Ther 27:36–44.
  • Hu Y, Sheng Y, Yu M, et al. (2016). Antioxidant activity of Inonotus obliquus polysaccharide and its amelioration for chronic pancreatitis in mice. Int J Biol Macromol 87:348–56.
  • Jevsevar S, Kunstelj M, Porekar VG. (2010). PEGylation of therapeutic proteins. Biotechnol J 5:113–28.
  • Jiao Y, Wang X, Jiang X, et al. (2017). Antidiabetic effects of Morus alba fruit polysaccharides on high-fat diet- and streptozotocin-induced type 2 diabetes in rats. J Ethnopharmacol 199:119–27.
  • Jølck RI, Binderup T, Hansen AE, et al. (2014). Injectable colloidal gold in a sucrose acetate isobutyrate gelating matrix with potential use in radiation therapy. Adv Healthc Mater 3:1680–7.
  • Li K, Zhuo C, Teng C, et al. (2016). Effects of Ganoderma lucidum polysaccharides on chronic pancreatitis and intestinal microbiota in mice. Int J Biol Macromol 93:904–12.
  • Li Z, Li H, Wang C, et al. (2016). Sodium dodecyl sulfate/β-cyclodextrin vesicles embedded in chitosan gel for insulin delivery with pH-selective release. Acta Pharm Sin B 6:344–51.
  • Lin X, Xu DS, Feng Y, et al. (2005). Determination of Ophiopogon japonicus polysaccharide in plasma by HPLC with modified postcolumn fluorescence derivatization. Anal Biochem 342:179–85.
  • Lin X, Xu DS, Feng Y, et al. (2006). Release-controlling absorption enhancement of enterally administered Ophiopogon japonicus polysaccharide by sodium caprate in rats. J Pharm Sci 95:2534–42.
  • Lin X, Yang S, Gou J, et al. (2012). A novel risperidone-loaded SAIB-PLGA mixture matrix depot with a reduced burst release: effects of solvents and PLGA on drug release behaviors in vitro/in vivo. J Mater Sci Mater Med 23:443–55.
  • Liu Z, Xing J, Zheng S, et al. (2016). Ganoderma lucidum polysaccharides encapsulated in liposome as an adjuvant to promote Th1-bias immune response. Carbohydr Polym 142:141–8.
  • Lu Y, Tang X, Cui Y, et al. (2008). In vivo evaluation of risperidone-SAIB in situ system as a sustained release delivery system in rats. Eur J Pharm Biopharm 68:422–9.
  • Okumu FW, Dao l. N, Fielder PJ, et al. (2002). Sustained delivery of human growth hormone from a novel gel system: SABER. Biomaterials 23:4353–8.
  • O’Neill HS, O’Sullivan J, Porteous N, et al. (2017). A collagen cardiac patch incorporating alginate microparticles permits the controlled release of HGF and IGF-1 to enhance cardiac stem cell migration and proliferation. J Tissue Eng Regen Med. DOI:10.1002/term.2392.
  • Parent M, Nouvel C, Koerber M, et al. (2013). PLGA in situ implants formed by phase inversion: critical physicochemical parameters to modulate drug release. J Control Release 172:292–304.
  • Shahsavari A, Azad M, Mobarra N, et al. (2016). Calprotectin pegylation enhanced its physical and structural properties. Protein J 35:363–70.
  • Shi X, Lin X, Yao C, et al. (2015). Injectable long-acting in situ forming systems for radix ophiopogonis polysaccharide. Int J Biol Macromol 72:553–9.
  • Shi X, Lin X, Zheng X, et al. (2014). Injectable long-acting systems for radix ophiopogonis polysaccharide based on mono-PEGylation and in situ formation of a PLGA depot. Int J Nanomedicine 9:5555–63.
  • Solorio L, Sundarapandiyan D, Olear A, et al. (2015). The effect of additives on the behavior of phase sensitive in situ forming implants. J Pharm Sci 104:3471–80.
  • Sun G, Lin X, Shen L, et al. (2013). Mono-PEGylated radix ophiopogonis polysaccharide for the treatment of myocardial ischemia. Eur J Pharm Sci 49:629–36.
  • Sun M, Zhao W, Xie Q, et al. (2015). Lentinan reduces tumor progression by enhancing gemcitabine chemotherapy in urothelial bladder cancer. Surg Oncol 24:28–34.
  • Wang LL, Burdick JA. (2017). Engineered hydrogels for local and sustained delivery of RNA-interference therapies. Adv Healthc Mater 6:1601041.
  • Wang S, Zhang Z, Lin X, et al. (2010). A polysaccharide, MDG-1, induces S1P1 and bFGF expression and augments survival and angiogenesis in the ischemic heart. Glycobiology 20:473–84.
  • Wang X, Wenk E, Hu X, et al. (2007). Silk coatings on PLGA and alginate microspheres for protein delivery. Biomaterials 28:4161–9.
  • Wang S, Lin X, Wang LY, et al. (2012). A polysaccharides MDG-1 augments survival in the ischemic heart by inducing S1P release and S1P1 expression. Int J Biol Macromol 50:734–40.
  • Wright JC, Burgess DJ, eds. (2012) Long acting injections and implants, advances in delivery science and technology. New York (NY): Springer.
  • Xu D, Feng Y, Lin X, et al. (2005). Isolation, purification and structural analysis of a polysaccharide MDG-1 from Ophiopogon japonicas. Acta Pharmaceutica Sinica 40:636–9.
  • Yamaoka T, Tabata Y, Ikada Y. (1994). Distribution and tissue uptake of poly(ethylene glycol) with different molecular weights after intravenous administration to mice. J Pharm Sci 83:601–6.
  • Zhang K, Shi X, Lin X, et al. (2015). Poloxamer-based in situ hydrogels for controlled delivery of hydrophilic macromolecules after intramuscular injection in rats. Drug Deliv 22:375–82.